Shear wave elastography in hepatitis C patients before and after antiviral therapy

Table 1 Clinical characteristics in the Naïve and sustained virological response group

Characteristics	Naïve group(n = 85)	SVR group(n = 51)	P value
Age (yr)	63.5 ± 13.7	64.9 ± 10.2	0.9726
Sex (male/female)	43/42	27/24	0.79039
AST (IU/L)	55.4 ± 38.7	29.2 ± 16.8	0.00001
ALT (IU/L)	61.9 ± 50.1	23.9 ± 18.0	0.00001
Total bilirubin (mg/dL)	0.89 ± 0.36	0.95 ± 0.33	0.14736
Serum albmin (g/dL)	4.10 ± 0.46	4.32 ± 0.44	0.01049
WBC (× 103/mm3)	5.21 ± 1.83	5.24 ± 1.56	0.79015
Hb (g/dL)	13.9 ± 1.6	14.1 ± 1.5	0.47879
Platelet (× 104/mm3)	14.5 ± 6.4	14.5 ± 5.7	0.89078
Prothrombin activity (%)	97.5 ± 12.1	96.9 ± 13.1	0.98341
AFP (g/dL)	9.6 ± 10.6	5.1 ± 3.3	0.00773
Type IV collagen (ng/mL)	180.5 ± 71.8	179.2 ± 71.6	0.62913
P-III-P (U/mL)	0.92 ± 0.27	0.81 ± 0.31	0.00215
Hyaluronic acid (ng/mL)	191.5 ± 290.3	102.1 ± 93.5	0.24908
M2BPGi (COI)	3.67 ± 4.41	2.03 ± 2.49	0.00546
FIB-4 index	4.44 ± 4.21	3.39 ± 2.63	0.37443

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; WBC: White blood cell; P-III-P: Procollagen III peptide; M2BP: Mac-2 binding protein; COI: Cut-off index.